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Abstract. 
 
Increased energy metabolism in the circulat-
ing blood platelet plays an essential role in platelet plug 
formation and clot retraction. This increased energy 
consumption is mainly due to enhanced anaerobic con-
sumption of glucose via the glycolytic pathway. The aim 
of the present study was to determine the role of glu-
cose transport as a potential rate-limiting step for hu-
man platelet glucose metabolism. We measured in iso-
lated platelet preparations the effect of thrombin and 
ADP activation, on glucose transport (2-deoxyglucose 
uptake), and the cellular distribution of the platelet glu-
cose transporter (GLUT), GLUT-3. Thrombin (0.5 
U/ml) caused a pronounced shape change and secretion 
of most 
 
a
 
-granules within 10 min. During that time glu-
cose transport increased approximately threefold, con-
comitant with a similar increase in expression of 
GLUT-3 on the plasma membrane as observed by im-
munocytochemistry. A major shift in GLUT-3 labeling 
was observed from the 
 
a
 
-granule membranes in resting 
platelets to the plasma membrane after thrombin treat-
ment. ADP induced shape change but no significant 
 
a
 
-granule secretion. Accordingly, ADP-treated plate-
lets showed no increased glucose transport and no in-
creased GLUT-3 labeling on the plasma membrane. 
These studies suggest that, in human blood platelets, in-
creased energy metabolism may be precisely coupled to 
the platelet activation response by means of the trans-
location of GLUT-3 by regulated secretion of 
 
a
 
-gran-
ules. Observations in megakaryocytes and platelets 
freshly fixed from blood confirmed the predominant 
GLUT-3 localization in 
 
a
 
-granules in the isolated cells, 
except that even less GLUT-3 is present at the plasma 
membrane in the circulating cells (
 
z
 
15%), indicating 
that glucose uptake may be upregulated five to six 
times during in vivo activation of platelets.
 
P
 
latelets
 
 play a crucial role in hemostasis and
thrombosis. They originate from megakaryocytes in
the bone marrow and adhere to sites of injury. In
their resting state, platelets are nonadhesive, have a dis-
coid shape, and contain a large number of 
 
a
 
-granules. The
 
a
 
-granules, which are the most abundant granule type in
these cells, contain adhesive proteins such as fibrinogen,
fibronectin, von Willebrand factor (Sixma et al., 1989;
Sander et al., 1983), and growth factors such as TGF-
 
b
 
 and
PDGF (Linder et al., 1979). At sites of injury the platelets
become activated, a process that promotes the formation
of a platelet thrombus and wound healing. Platelet activa-
tion can be subdivided into several discrete steps. The first
step is the adhesion to exposed components of the suben-
dothelium, which is rapidly followed by a change in cell
shape (Sixma et al., 1987
 
a
 
,
 
b
 
), due to rearrangement of ac-
tin filaments and microtubules, both of which maintain the
discoid nature of the resting platelet (Behnke, 1974;
Hartwig, 1992). The next step involves the aggregation of
platelets, which occurs simultaneously with the exocytosis
of the 
 
a
 
-granules. Finally, the actin filaments associate
with myosin in a process that resembles skeletal muscle
contraction (Cohen et al., 1982; Fox et al., 1992). This step
facilitates platelet retraction, which is responsible for clot
contraction.
Each of these steps in the functional activation sequence
of the platelet must result in a significant increase in the
energy requirements of this cell. However, there is little
information available regarding the type of fuel used by
the platelet under these conditions, which of these steps is
the most energy costly, or the points of regulation within the
intermediary metabolic pathways that facilitate these
changes. The resting platelet relies predominantly on the
anaerobic metabolism of blood-borne glucose as its major
source of energy (Akkerman, 1978, 1987) despite the pres-
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ence of mitochondria and glycogen particles within these
cells. It is likely that platelet plug formation and clot re-
traction are also highly dependent on extracellular glucose
as it has been shown that there is a direct relationship be-
tween platelet retraction efficiency and glycolytic flux
(Bettex-Galland and Luscher, 1959). In fact, these and fur-
ther studies showed that glucose improves platelet retrac-
tion efficiency in in vitro assays, suggesting that the con-
sumption of glucose by platelets and the efficiency of clot
retraction must be somehow linked.
Skeletal and heart myocytes are other cell types in
which rapid and marked changes in carbohydrate metabo-
lism meet the increased energy demands of actomyosin
contraction, similarly to the platelet. In these cells, the
very first step in the glycolytic breakdown of extracellular
glucose, i.e., glucose entry into the cell, appears to be a
major rate-determining step (Ziel et al., 1988). Muscle
contraction and other stimuli such as insulin stimulate glu-
cose transport by triggering the movement of a facilitative
glucose transporter (GLUT)
 
1
 
 known as GLUT-4 from an
intracellular compartment to the cell surface (James et al.,
1994; Cushman and Wardzala, 1980; Suzuki and Kono,
1980). Upon cessation of muscle contraction or removal of
the agonist, GLUT-4 is retrieved from the cell surface, and
glucose transport and glucose use return to resting levels.
In view of the possible similarity between platelets and
myocytes in terms of the contraction-induced changes in
carbohydrate metabolism, we have investigated the poten-
tial role of glucose transport in platelet activation. We
present evidence that activation of platelets with thrombin
results in a significant increase in 2-deoxyglucose (2-DG)
uptake. Stimulation with ADP, under conditions where
platelet secretion was inhibited, did not cause a significant
change in platelet 2-DG uptake. Recently it was reported
that GLUT-3 is the main glucose transporter isoform ex-
pressed in platelets (Craik et al., 1995). Accordingly, we
show immunocytochemically that in resting platelets GLUT-3
is localized to the 
 
a
 
-granule membrane from where it
moves to the cell surface in response to thrombin. This
regulated translocation of GLUT-3 is responsible for the
increased uptake of 2-DG.
 
Materials and Methods
 
Antibodies
 
The anti–human GLUT-3 antibody was raised against a synthetic peptide
corresponding to the last 12 amino acids in the carboxy terminus of the
protein. This antibody has been extensively characterized and is highly
specific for human GLUT-3 (Harris et al., 1992). Gold particles, prepared
as described previously (Slot and Geuze, 1985), were conjugated to pro-
tein A (Roth et al., 1978).
 
Platelet Isolation
 
Blood was taken from healthy donors and was anticoagulated with 0.1 vol
of 0.13 M sodium citrate. Platelet-rich plasma was obtained by centrifuga-
tion of whole blood at 180 
 
g
 
 for 10 min at 22
 
8
 
C, and then mixed in a 1:1 ra-
tio with Krebs-Ringer buffer, pH 5.0 (4 mM KCl, 100 mM NaCl, 20 mM
NaHCO
 
3
 
, 2 mM Na
 
2
 
SO
 
4
 
, 4.7 mM citric acid, 14.2 tri-sodium citrate). The
platelet pellet was washed twice with the same buffer at pH 6.0. Alterna-
tively, fresh whole blood was collected directly from the vein into fixative
containing 2.4% paraformaldehyde and 0.24% glutaraldehyde in 0.1 M so-
dium phosphate buffer, pH 7.4 (1:5 volume ratio). For biochemical analysis,
samples of the washed platelet suspension were resuspended in Krebs-
Ringer buffer, pH 7.4, adjusted to 2 
 
3
 
 10
 
9
 
 platelets per ml, and used within 1 h.
 
Bone Marrow Megakaryocytes
 
Normal bone marrow samples were obtained after informed consent from
a patient undergoing heart surgery. The megakaryocyte-rich cell suspen-
sion was obtained by centrifugation on Ficoll-Paque (Research Grade;
Pharmacia, Uppsala, Sweden). The cells were fixed with a mixture of 2%
paraformaldehyde and 0.2% glutaraldehyde, and then processed for cryo-
sectioning and immunolabeling as described below.
 
[
 
14
 
C]2-DG Uptake
 
Aliquots (200 
 
m
 
l) of the washed platelet suspension were diluted in 1.8 ml
0.1 M Hepes- NaCl (0.01 M Hepes, 0.15 M NaCl, pH 7.4) to obtain a final
platelet concentration of 2 
 
3
 
 10
 
8
 
/ml. The platelet samples were warmed to
37
 
8
 
C and incubated either in the absence or presence of thrombin. A
dose-dependent stimulation was achieved using concentrations of 0.02,
0.2, and 0.5 U/ml thrombin, respectively. After stimulation for 7 min,
[
 
14
 
C]2-DG was added to the platelet suspension at a final concentration of
10 
 
m
 
M, and the incubation was continued for 3 min. Alternatively, plate-
lets were incubated for 7 min with ADP (10 
 
m
 
M), followed by the addition
of 10 
 
m
 
M [
 
14
 
C]2-DG as described above. In this case the platelets were
preincubated at 37
 
8
 
C for 10 min with 30 
 
m
 
M indomethacin, a specific in-
hibitor of cyclo-oxygenase, which prevents secretion during ADP stimula-
tion (Kaplan et al., 1979). The [
 
14
 
C]2-DG uptake was arrested by the addi-
tion of 10 
 
m
 
M cytochalasin B. The platelet samples were washed three
times with 0.1 M PBS, 50-
 
m
 
l samples were taken, and the total protein
content was measured. The platelet pellet was dissolved in 500 
 
m
 
l 1 N
NaOH and counted in a liquid scintillation counter.
 
Cryosectioning and Immunolabeling
 
Platelet samples were incubated as described for the measurements of
2-DG uptake except that nonradiolabeled 2-DG was used for the incuba-
tion. At the conclusion of the 10 min, incubation platelets were immedi-
ately fixed using 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M
sodium phosphate buffer. Samples were then rinsed three times in 0.1 M
sodium phosphate buffer and embedded in 10% gelatin in PBS at 37
 
8
 
C.
The gelatin was solidified at 4
 
8
 
C, and cut into small blocks. After over-
night infiltration in 2.3 M sucrose at 4
 
8
 
C, the cells were frozen in liquid ni-
trogen. Ultrathin cryosectioning and immunogold labeling were per-
formed as described before (Slot et al., 1991). Sections were picked up
with a drop of a 1:1 mixture of 2.3 M sucrose and 1.8% methyl cellulose
(25 centipoise; Fluka AG, Buchs, Switzerland), thawed, and transferred to
Formvar carbon-coated copper grids (Liou et al., 1996). The sections were
subsequently immunolabeled at room temperature by floating on drops
containing the diluted antibody. After incubation, the sections were
washed on distilled water, stained for 5 min with uranyl-oxalate, pH 7.0,
washed again, and embedded in a mixture of 1.8% methyl cellulose and
0.3% uranyl acetate at 4
 
8
 
C. For quantitative analysis of the GLUT-3 label-
ing, random electron micrographs were taken at a nominal magnification
of 12,000 from directly fixed platelets, nonstimulated washed platelets,
and after stimulation with ADP and thrombin. Gold particles were
counted over 
 
a
 
-granules, plasma membrane, including the open canalicu-
lar system (OCS), and undefined structures. Gold particle numbers were
expressed as a percentage of the total.
 
Results
 
[
 
14
 
C]2-DG Uptake in Platelets
 
The measurement of 2-DG uptake provides an estimate of
glucose transport, as this analogue is transported and
phosphorylated like glucose but does not undergo subse-
quent metabolism. Stimulation with thrombin caused a
rapid increase in 2-DG uptake in human platelets (Fig. 1).
The amount of 2-DG uptake was 1.2-fold when a low dose
of thrombin (0.05 U/ml) was used, while at a dose of 0.5
U/ml a 2.8-fold increase was observed. The specificity of
 
1. 
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the 2-DG uptake was confirmed by using cytochalasin B, a
specific inhibitor of the facilitative glucose transporter
(Jung and Rampal, 1977). 2-DG uptake was inhibited by
 
.
 
90% in the presence of 10 
 
m
 
M cytochalasin B, irrespec-
tive of the activation state of the platelets (data not
shown).
In accordance with a previous study on Western blots of
whole platelet lysates (Craik et al., 1995), we were unable
to detect any significant expression of GLUT-1, GLUT-2,
or GLUT-4 using isoform-specific antibodies. It is unlikely
that platelets express GLUT-5 because this isoform has a
selective preference for fructose (Burant et al., 1992), and
previous studies have shown that platelets do not trans-
port fructose (Akkerman, 1978). Significant labeling was,
however, observed using an antibody specific for human
GLUT-3, confirming that this is probably the major glu-
cose transporter isoform expressed in these cells (Craik et
al., 1995). We therefore next investigated the intracellular
localization of GLUT-3 in human platelets and their pre-
cursor, the megakaryocyte, to further explain the activa-
tion-dependent increase in 2-DG uptake.
 
Localization of GLUT-3 in Resting Platelets
 
Ultrathin cryosections of fixed human platelets were im-
munolabeled with antibodies specific for GLUT-3. In rest-
ing platelets, from blood that was collected in fixative, sig-
nificant immunolabeling of the 
 
a
 
-granules was observed
(Fig. 2). Most of the immunogold labeling was situated at
the cytoplasmic face of the granules, consistent with the
fact that the antibody was raised against the cytoplasmic
carboxy terminus of GLUT-3 (Harris et al., 1992). Low la-
beling of the platelet plasma membrane, including the con-
nected OCS, was also encountered under these conditions.
The relative distribution of GLUT-3 was quantified by
counting the gold particles associated with 
 
a
 
-granules, sur-
face membrane, OCS, and undefined structures (Table I).
In resting platelets, 75% of the total gold labeling was as-
sociated with the limiting membrane of the 
 
a
 
-granules and
15% was detected at the platelet outer surface and the
OCS. The remaining 10% was attributed to structures that
were not easily identified. This may represent in part la-
beling of grazing sections over 
 
a
 
-granule membranes and
nonspecific background staining. When megakaryocytes
isolated from bone marrow were immunolabeled with an-
tibodies specific for GLUT-3, we found labeling patterns
similar to that in the resting platelets: predominant label-
ing of the 
 
a
 
-granules, and additionally a low expression in
the Golgi complex and demarcating membranes, the pre-
cursor of the platelet cell surface (data not shown).
 
Effects of Thrombin and ADP on GLUT-3 Localization
 
In isolated control platelets that were fixed after 10-min
incubation in Hepes buffer, we found evidence for mild ac-
tivation. This is a well-established phenomenon and is
hard to avoid during the washing steps of these fragile
cells, in spite of all precautions taken. However, the gen-
eral morphology of the washed platelets used in our exper-
iments resembled that in resting state fairly well, contain-
ing still numerous 
 
a
 
-granules, and they did not exhibit the
characteristic shape change of an activated platelet. Under
these conditions, 67% of the total immunogold labeling
was associated with the 
 
a
 
-granules and 23% was found on
OCS and surface membranes (Table I). In response to 0.05
U/ml of thrombin, the platelets underwent the shape
changes characteristic for a low stimulatory response (i.e.,
centralization of 
 
a
 
-granules and the beginning of cell sur-
face ruffling). No substantial redistribution of GLUT-3
was observed under these conditions. Incubation with 0.2
and 0.5 U/ml thrombin caused a marked activation of the
platelets, concomitant with a substantial redistribution of
GLUT-3 to the platelet cell surface membranes. A major-
ity of the 
 
a
 
-granules had fused with membranes of the cell
surface and the OCS, leaving large vacuoles with released
contents in the center (Fig. 3, 
 
a
 
 and 
 
b
 
). A dose of 0.05, 0.2,
or 0.5 U/ml thrombin caused a 1.4-, 2.8-, or 3.3-fold in-
crease in GLUT-3 labeling at the plasma membrane, con-
comitant with a 1.3-, 1.9-, or 2.8-fold increase in 2-DG up-
take, when compared with controls.
To determine if the changes in 2-DG uptake were trig-
gered by changes in cell shape or activation of the platelet
contractile apparatus, the effect of ADP on GLUT-3 local-
ization was measured. In agreement with previous find-
ings, ADP caused characteristic changes in platelet shape,
i.e., centralization of 
 
a
 
-granules and the formation of
pseudopodal extensions (Fig. 4). Under the experimental
conditions, ADP had no effect on the number of intracel-
lular 
 
a
 
-granules, as well as on the distribution of GLUT-3
in platelets (Fig. 4; Table I), which is consistent with the in-
ability of ADP to trigger a change in 2-DG uptake (Fig. 1).
 
Discussion
 
In the present study we show that activation of human
platelets with thrombin causes a rapid stimulation of glu-
Figure 1. Glucose transport activity in human platelets. Isolated
platelets were either nonstimulated or stimulated with 10 mM
ADP or 0.05, 0.2, and 0.5 U/ml thrombin, respectively. The
[14C]2-DG uptake was measured as described in Materials and
Methods. The increase in 2- DG uptake upon stimulation is ex-
pressed relative to the basal 2-DG values of nonstimulated plate-
lets. The values represent the mean 6 SEM of three separate ex-
periments. 
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Figure 2. Ultrastructural localization of GLUT-3 in human platelets. Frozen thin-sections of resting platelets immediately fixed in
whole blood were immunolabeled with an antibody specific for GLUT-3, followed by protein A conjugated to 10 nm gold. The platelets
still have their discoid shape. The majority of the label is associated with the limiting membrane of the a-granules. Note that the gold
particles are often situated at the cytoplasmic face of the membrane, and occasionally in a grazing section with the tip of an a-granule
membrane (arrow). Some label is also associated with the plasma membrane (arrowheads). (Stars) OCS. Bar, 200 nm.
 
Table I. Intracellular Distribution of GLUT-3 in Blood Platelets
 
Isolated platelets
Fresh fixed platelets Thrombin ADP
Resting Control 0.05 0.2 0.5 10
 
 
U/ml 
 
m
 
M
 
Plasma membrane 14.8 (1.1) 23.5 (1.6) 32.0 66.9 (3.9) 78.8 25.6
Cell surface 9.9 (1.3) 14.3 (1.0) 22.0 45.4 (2.0) 57.0 17.3
OCS 4.9 (1.3) 9.2 (1.0) 10.0 21.5 (2.4) 21.8 8.3
 
a
 
-Granules 74.8 (2.8) 67.5 (2.2) 61.9 26.1 (5.6) 13.8 66.5
Undefined 10.4 (2.1) 9.0 (1.6) 6.1 7.0 (2.0) 7.4 7.9
 
n
 
36 1 4 1 2
 
Gold particles were counted over cryosections of GLUT-3–labeled platelets, in resting state and after activation by thrombin or ADP, and were attributed to the items indicated.
Number represent percentages (
 
6
 
 SEM). The number of experiments (
 
n
 
) is indicated at the bottom of the table. In each experiment at least 1,000 gold particles were counted in
 
z
 
50 randomly photographed platelet profiles.
 
Figure 3.
 
Distribution of GLUT-3 in activated platelets. Activation with both 0.2 U/ml thrombin (
 
a
 
) and 0.5 U/ml thrombin (
 
b
 
) results
in a significant loss of the 
 
a
 
-granules and a remarkable shape change to a ruffled cell surface. Some platelets had retained 
 
a
 
-granules, a
finding which was more often encountered at the lower dose of thrombin (
 
a
 
). The translocation of GLUT-3 to the OCS (
 
stars
 
) and to
the cell surface is obvious, particularly to the pseudopods. (
 
b
 
, 
 
arrowheads
 
). Bar, 250 nm. 
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cose uptake, suggesting that this may be a key metabolic
step for the generation of ATP to sustain the increased en-
ergy demands during thrombus formation. This acute ele-
vation in transport is precisely coupled to platelet activa-
tion via the efficient targeting of the major facilitative
transporter found in this cell, GLUT-3, from the intracel-
lular 
 
a
 
-granules toward the cell surface. As these granules
fuse with the cell surface, there is a significant increase in
surface levels of GLUT-3, accompanied by an increased
glucose transport activity, which was of similar magnitude
at the different levels of activation (Fig. 1 vs Table I) We
could not measure glucose uptake in circulating human
blood platelets, but our immunocytochemical data indi-
cate that, compared with the very low levels (
 
z
 
15%) in
resting, directly fixed platelets, a five- to sixfold increase in
GLUT-3 surface expression occurs during full platelet ac-
tivation. The parallel course of increases in GLUT-3 sur-
face expression and glucose uptake that we measured in
isolated platelet preparations suggests that glucose trans-
port likewise can be upregulated five- to sixfold when cir-
culating platelets are activated in vivo.
Previous studies have shown that extracellular glucose is
an important source of energy for human platelets (Ak-
kerman, 1978, 1987). Moreover, much of the metabolic
flux in platelets appears to be directed toward lactate pro-
duction. In view of the relatively low energy yield of this
pathway (
 
z
 
2 mol ATP per mol glucose), compared with
the TCA cycle (
 
z
 
36 mol ATP per mol glucose), it is likely
that the flux through this pathway must increase substan-
tially during platelet activation when the ATP require-
ments to maintain contraction of the actomyosin system as
well as other functions are likely to be quite significant.
However, the rate-determining steps in the glycolytic
pathway that facilitate these changes in platelet metabo-
lism have not been defined. The free intracellular glucose
concentration is very low in platelets, suggesting that the
rate of flux through this step is not in equilibrium with
other steps in the glycolytic pathway (Akkerman, 1978,
1987). This provided a clue that the glucose transport step
could play an important role as a rate-determining step in
this cell. Until recently, however, very little was known
concerning the platelet glucose transport system.
Over the past decade a family of facilitative glucose
transporters have been identified in mammals (Mueckler,
1994). Each member of this family, referred to as GLUTs
1–7, displays a unique tissue distribution, as well as charac-
teristic kinetic properties that appear to enable different
cell types to respond appropriately to a particular meta-
bolic situation. For example, GLUT-2, which is found in
liver and pancreatic B cells, has a very low affinity for glu-
Figure 4. GLUT-3 expression after stimulation with 10 mM ADP. The shape changes characteristic for ADP stimulation are observed
(i.e., centralization of a-granules and some cell surface ruffling ). A similar morphology is observed when the low dose of 0.05 U/ml
thrombin is used (not shown). The majority of the label is still associated with the membranes of the a-granules. Some label is observed
at developing pseudopods. Bar, 200 nm. 
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cose (Colville et al., 1993). This is probably advantageous
for these particular cells, enabling them to transmit
changes in the circulation to the cell interior. Using anti-
bodies specific for each glucose transporter isoform, it was
recently reported that platelets predominantly express
GLUT-3 (Craik et al., 1995), which was confirmed by the
present immunolocalization study. GLUT-3 has a particu-
larly low 
 
K
 
m
 
 for glucose, allowing it to transport efficiently
even when blood glucose levels are very low (Gould et al.,
1991). Since the internal environment of a platelet plug is
deprived of blood flow, this may explain the selective ad-
vantage of using the GLUT-3 isotype. The irreversible sur-
face expression of GLUT-3 may be a desirable feature to
ensure that, after the secretory process is complete, high
cell surface levels of GLUT-3 are maintained. It enables
the platelets to maintain prolonged access to extracellular
glucose throughout the course of hemostatic plug forma-
tion, thereby providing a continuous source of energy for
platelet contraction.
The major tissues in which GLUT-3 expression has been
reported are brain (Kayano et al., 1988), mouse embryos
(Pantaleon et al., 1997), sperm (Burant and Davidson,
1994), and polarized epithelial cells derived from human
tumors (Harris et al., 1992). The subcellular distribution of
GLUT-3 in each of these tissues differs from that of other
transporters, thus providing an unique feature of this iso-
form. In mouse embryos, MDCK cells (Pascoe et al.,
1996), and CaCo2 cells (Harris et al., 1992), GLUT-3 is
targeted to the apical cell surface. In neurons, GLUT-3 ap-
pears to be targeted to axons (James, D.E., unpublished
data), whereas in sperm it is found predominantly in the
tail (Slot, J.W., and D.E. James, unpublished observa-
tions). Hence, it will be of interest to determine if similar
motifs are responsible for maintaining each of these
unique targeting phenotypes, and if there is some link be-
tween each of these targeting events and the localization of
GLUT-3 to the limiting membrane of the 
 
a
 
-granules in
platelets. A targeting motif that regulates the sequestra-
tion of P-selectin in secretory granules has been identified
(Koedam et al., 1992), but we have been unable to identify
a motif resembling this in GLUT-3.
In all cell types studied, GLUT-3 molecules are almost
exclusively confined to the plasma membrane (Pascoe et
al., 1996; Harris et al., 1992), in agreement with the ab-
sence of a consensus internalization signal in the cytosolic
domains of GLUT-3 (Asano et al., 1992). In contrast,
platelets harbor most of their GLUT-3 intracellularly in
 
a
 
-granule membranes. These are most likely biosynthetic
GLUT-3 molecules that are stored in the 
 
a-granules before
their translocation to the cell surface by stimulated a-gran-
ule release. This is an irreversible process and occurs only
once in the platelet’s life time, during activation. The only
glucose transporter normally stored intracellularly in rest-
ing cells is GLUT-4, which resides in an endosome-related
compartment until it becomes transiently expressed at the
cell surface after stimulation (James et al., 1994). Interest-
ingly, we have recently observed a major pool of intracel-
lular GLUT-4 molecules residing in the membranes of
regulated secretory granules in atrial myocytes (Slot et al.,
1997). Several lines of evidence indicated that these GLUT-4
molecules derive from endocytosis rather than from the
biosynthetic pathway. Thus, while atrial myocytes seem to
exploit secretion of their storage granules to ensure stimu-
lus-dependent repetitive endocytotic and translocation cy-
cles of GLUT-4, platelets store biosynthetic GLUT-3 in
a-granules during differentiation from megakaryocytes
until the platelets are stimulated to release the a-granules
before disintegration during clot formation.
Received for publication 17 February 1997 and in revised form 15 May
1997.
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